Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis

Authors :: María José Ramírez
Anna Angona
Francisco Cervantes
María Teresa Gómez-Casares
Elvira Mora
Clara Martínez-Valverde
Natalia Estrada
Juan-Gonzalo Correa
Manuel Pérez-Encinas
María Antonia Durán
Elisa Arbelo
María Isabel Mata-Vázquez
Ana Kerguelen
Nieves Somolinos
Juan Carlos Hernández-Boluda
María Luisa Antelo
Maria Laura Fox
Patricia Velez
Angel Ramirez Payer
Alberto Alvarez-Larrán
Beatriz Cuevas
Irene Pastor-Galán
Valentín García-Gutiérrez
Francisca Ferrer-Marín
Rosa Ayala
Elena Magro
en representación del Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas
José María Raya
Source :: MEDICINA CLINICA, r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA, instname
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.
Abstract: BACKGROUND AND OBJECTIVE MYELOFIBROSIS: is an infrequent chronic myeloproliferative neoplasm. We aimed to describe the clinico-biological characteristics, treatment, and evolutive course of myelofibrosis patients in Spain.; MATERIAL AND METHODS: A total of 1,000 patients from the Spanish Registry of Myelofibrosis diagnosed with primary (n=641) or secondary (n=359) myelofibrosis were analysed.; RESULTS: Median age was 68 years. The frequency of constitutional symptoms, moderate to severe anaemia (Hb

Subjects :: Moderate to severe
Pediatrics
medicine.medical_specialty
Constitutional symptoms
business.industry
medicine.disease
Transplantation
03 medical and health sciences
0302 clinical medicine
Chronic Myeloproliferative Neoplasm
Clinical heterogeneity
medicine
Elderly people
030212 general & internal medicine
Myelofibrosis
business
Prognostic models

Full Text Access

Tools